CBD Co. Issues Recall After FDA Warning Letter

CBD Co. Issues Recall After FDA Warning Letter BIOTA Biosciences, a CBD injections manufacturer, has issued a recall of three of its products a few weeks after the U.S. Food and Drug Administration warned the company against touting its wares as treatments for opioid addiction. CBD Co. Issues Recall After FDA Warning Letter #CBD #Hemp https://www.law360.com/cannabis/articles/1275912?utm_source=rss&utm_medium=rss&utm_campaign=section May 21, 2020 8:22 pm

Leave Your Reply